Antifungals, Antivirals & Anthelmintics

Systemic antifungals, antivirals and anthelmintics supplied with full batch documentation — including fluconazole at the injection concentration of 2 mg/mL carried on the WHO Model List, and albendazole as a listed intestinal anthelmintic.

5 products Fluconazole injection · ribavirin injection · amantadine · albendazole · picrasma
4 sourced statements Reference: WHO Model List of Essential Medicines, 24th List (September 2025) Reviewed 2026-10-05

Fluconazole appears on the WHO Model List as a 50 mg capsule, an injection of 2 mg/mL in vial, and oral liquids at 50 mg/5 mL. It is a systemic antifungal mainly active against Candida albicans and Cryptococcus neoformans.

At a glance

  • Fluconazole is listed as a 50 mg capsule and an injection of 2 mg/mL in vial.
  • MSF lists fluconazole for oesophageal and oropharyngeal candidiasis and for cryptococcal meningitis.
  • The oral suspension is intended for paediatric use and keeps for two weeks after reconstitution.
  • Ribavirin is listed for hepatitis C specifically in combination with direct-acting antivirals.
  • Albendazole appears on the Model List among intestinal anthelmintics.

01What the published guidance says

Every statement below is drawn from WHO or MSF published material and linked to its source. We summarise; we do not reproduce. Statements marked as our own are commercial positions, not clinical guidance.

Fluconazole is carried on the Model List in both oral and intravenous form

The 24th WHO Model List (2025) lists fluconazole as a 50 mg capsule, an injection of 2 mg/mL in vial, an oral liquid of 50 mg/5 mL and a powder for oral liquid of 50 mg/5 mL, classified under antifungal medicines.

MSF positions fluconazole and its indications

MSF classifies fluconazole as a systemic antifungal mainly active against Candida albicans and Cryptococcus neoformans, listing use in oesophageal candidiasis, moderate to severe oropharyngeal candidiasis, secondary prophylaxis of recurrent candidiasis in immunocompromised patients, cryptococcal meningitis and secondary prophylaxis of cryptococcal infection. It notes the oral suspension is intended for paediatric use and keeps for two weeks after reconstitution.

Ribavirin's listing is specifically combination-based

The Model List carries ribavirin injection for intravenous administration and solid oral dosage forms, with the note that for hepatitis C it is used in combination with direct-acting antiviral medicines.

Albendazole is listed as an intestinal anthelmintic

Albendazole appears on the Model List among intestinal anthelmintics, a class that also includes ivermectin, levamisole, mebendazole, niclosamide, praziquantel and pyrantel.

02Products in this therapeutic group

Each entry links to its full specification page.

Products supplied by Sinophare Bio-technology Co., Ltd. in the Antifungals & Antivirals therapeutic area
Product Dosage form Presentation notes Detail
Fluconazole Injection 200mg per 100m Injection   View Fluconazole Injection 200mg per 100m →
Albendazole 200mg Tablets Tablet   View Albendazole 200mg Tablets →
Amantadine 100mg Capsules Capsule Antiviral & Parkinsonism Treatment Drug View Amantadine 100mg Capsules →
Picrasma Anti-Dysentery Capsules 200mg Capsule   View Picrasma Anti-Dysentery Capsules 200mg →
Ribavirin Injection 100mg Injection Broad-Spectrum Antiviral Infusion Solution View Ribavirin Injection 100mg →

5 products in this group · part of 186 finished dosage forms across 14 therapeutic areas.

03Specifying your order

The five things worth stating on a purchase order for this group, so the quotation comes back right first time.

Injection concentration

State 2 mg/mL, and the container volume your pharmacy expects, since fluconazole infusion is often supplied as a ready-to-use bag.

Oral presentation

Capsule strength, or oral liquid and powder for oral liquid. Confirm the fill volume for paediatric use.

Reconstitution and in-use period

For suspensions, state the in-use period your label must declare. The fluconazole oral suspension keeps for two weeks after reconstitution.

Combination labelling

For ribavirin, confirm that the label and leaflet state the combination-use restriction for hepatitis C.

Programme strength

For albendazole used in mass drug administration, confirm the strength your national programme has adopted.

04How we supply it

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Systemic antifungal

Fluconazole injection 200 mg/100 mL, matching the Model List injection concentration of 2 mg/mL, plus oral forms.

Antiviral

Ribavirin injection and amantadine capsules.

Anthelmintic

Albendazole 200 mg tablets, alongside our broader anti-infective range.

Documentation

COA with assay and related substances, stability data and registration support documents for anti-infective filings.

05Safety, labelling & regulatory notes

Points worth carrying into your tender, label review or clinical briefing.

  • Ribavirin is listed for hepatitis C specifically in combination with direct-acting antivirals. Do not promote it as monotherapy.
  • Fluconazole has significant drug-interaction potential, including QT-prolonging agents. Confirm the approved prescribing information for the destination market.
  • Anthelmintics used in mass drug administration programmes have population-level dosing considerations. Confirm the presentation your national programme has adopted.
  • Confirm local registration for each molecule. Registration support documents are supplied, but registration itself is the buyer's responsibility.

06Questions buyers ask

6 answers covering specification, documentation and regulatory questions for this group.

Is fluconazole on the WHO Essential Medicines List?
Yes. The 24th Model List carries fluconazole as a 50 mg capsule, injection 2 mg/mL in vial, oral liquid 50 mg/5 mL and powder for oral liquid.
What is fluconazole used for according to MSF guidance?
MSF lists oesophageal candidiasis, moderate to severe oropharyngeal candidiasis, secondary prophylaxis of recurrent candidiasis in immunocompromised patients, cryptococcal meningitis and secondary prophylaxis of cryptococcal infection.
Do you supply albendazole?
Yes — albendazole 200 mg tablets. Albendazole is listed on the Model List among intestinal anthelmintics.
Can ribavirin be used on its own?
No. The Model List specifies ribavirin for hepatitis C in combination with direct-acting antiviral medicines, not as monotherapy.
Do you supply fluconazole oral suspension for paediatric use?
Yes, alongside the capsule and injection. MSF notes the oral suspension is intended for paediatric use and keeps for two weeks after reconstitution, which your label's in-use period should reflect.
Can you supply albendazole for a mass drug administration programme?
Yes — albendazole 200 mg tablets, a listed intestinal anthelmintic. Confirm the strength and presentation your national programme has adopted.

07Related therapeutic areas

Adjacent groups you may want to combine on one purchase order.

Request a quotation for Antifungals & Antivirals

Send us the products, strengths and pack sizes you need, together with the destination country, and we will return a quotation with the documentation package and lead time. Registration support documents are provided with every order.

Request a quotation →
Or write to info@sinophare.com